Abstract
The activation of innate immune system is essential for the pathogenesis of nonalcoholic steatohepatitis (NASH). Among pattern recognition receptors, it is well-characterized that toll-like receptors (TLRs) are deeply involved in the development of NASH to reflect exposure of the liver to gut-driven endotoxins. In contrast, it has not been elucidated whether retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs) are similarly implicated in the disease progression. In the present study, we examined the expression of melanoma differentiation-associated antigen 5 (MDA5), known to be a member of RLRs, in a diet-induced murine model of NASH. The liver tissues were collected from C57BL/6 J mice at 1, 3, and 6 weeks after choline-deficient l-amino acid-defined high-fat diet (CDAHFD), and the expression of MDA5 was analyzed by western blotting, immunofluorescence (IF), and real-time quantitative PCR (qPCR). The results of western blotting showed that hepatic expression of MDA5 was increased at 3 and 6 weeks. In IF, MDA5-positive cells co-expressed F4/80 and CD11b, indicating they were activated macrophages, and these cells began to appear at 1 week after CDAHFD. The mRNA expression of MDA5 was significantly upregulated at 1 week. Additionally, we performed IF using liver biopsy specimens collected from 11 patients with nonalcoholic fatty liver diseases (NAFLD), and found that MDA5-positive macrophages were detected in eight out of eleven patients. In an in vitro study, MDA5 was induced upon stimulation with lipopolysaccharide in murine bone marrow-derived macrophages and THP-1 cells. Our findings suggest that MDA5 may be involved in the inflammation of NASH.
Similar content being viewed by others
References
White, D.L., F. Kanwal, and H.B. El-Serag. 2012. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systemic review. Clinical Gastroenterology and Hepatology 10 (12): 1342–1359.
Tilg, H., and A.R. Moschen. 2010. Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology 52 (5): 1836–1846.
Marra, F., and G. Svegliati-Baroni. 2018. Lipotoxicity and the gut-liver axis in NASH pathogenesis. Journal of Hepatology 68 (2): 280–295.
Hui, J.M., A. Hodge, G.C. Farrell, J.G. Kench, A. Kriketos, and J. George. 2004. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40 (1): 46–54.
Chassaing, B., L. Etienne-Mesmin, and A.T. Gewirtz. 2014. Microbiota-liver axis in hepatic disease. Hepatology 59 (1): 328–339.
Wen, Y., J. Lambrecht, C. Ju, and F. Tacke. 2021. Hepatic macrophages in liver homeostasis and disease-diversity, plasticity and therapeutic opportunities. Cellular & Molecular Immunology 18 (1): 45–56.
Seki, E., and D.A. Brenner. 2008. Toll-like receptors and adaptor molecules in liver disease: Update. Hepatology 48 (1): 322–335.
Blériot, C., and F. Ginhoux. 2019. Understanding the heterogeneity of resident liver macrophages. Frontiers in Immunology 10: 2694.
Karlmark, K.R., R. Weiskirchen, H.W. Zimmermann, N. Gassler, F. Ginhoux, C. Weber, M. Merad, T. Luedde, C. Trautwein, and F. Tacke. 2009. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50 (1): 261–274.
Rivera, C.A., P. Adegboyega, N. van Rooijen, A. Tagalicud, M. Allman, and M. Wallace. 2007. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. Journal of Hepatology 47 (4): 571–579.
Miura, K., L. Yang, N. van Rooijen, H. Ohnishi, and E. Seki. 2012. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. American Journal of Physiology. Gastrointestinal and Liver Physiology 302 (11): G1310-1321.
Yoneyama, M., M. Kikuchi, K. Matsumoto, T. Imaizumi, M. Miyagishi, K. Taira, E. Foy, Y.M. Loo, M. Gale Jr., S. Akira, S. Yonehara, A. Kato, and T. Fujita. 2005. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. The Journal of Immunology 175 (5): 2851–2858.
Crampton, S.P., J.A. Deane, L. Feigenbaum, and S. Bolland. 2012. Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. The Journal of Immunology 188 (3): 1451–1459.
Asdonk, T., M. Steinmetz, A. Krogmann, C. Ströcker, C. Lahrmann, I. Motz, K. Paul-Krahe, A. Flender, T. Schmitz, W. Barchet, G. Hartmann, G. Nickenig, and S. Zimmer. 2016. MDA-5 activation by cytoplasmic double-stranded RNA impairs endothelial function and aggravates atherosclerosis. Journal of Cellular and Molecular Medicine 20 (9): 1696–1705.
Tatsuta, T., T. Imaizumi, T. Shimoyama, M. Sawaya, T. Kunikazu, T. Matsumiya, K. Satoh, and S. Fukuda. 2012. Expression of melanoma differentiation associated gene 5 is increased in human gastric mucosa infected with Helicobacter pylori. Journal of Clinical Pathology 65 (9): 839–843.
Imaizumi, T., T. Aizawa-Yashiro, K. Tsuruga, H. Tanaka, T. Matsumiya, H. Yoshida, T. Tatsuta, F. Xing, R. Hayakari, and K. Satoh. 2012. Melanoma differentiation-associated gene 5 regulates the expression of a chemokine CXCL10 in human mesangial cells: Implications for chronic inflammatory renal diseases. Tohoku Journal of Experimental Medicine 228 (1): 17–26.
Sadler, A.J. 2018. The role of MDA5 in the development of autoimmune disease. Journal of Leukocyte Biology 103 (2): 185–192.
Nakashima, R., Y. Imura, S. Kobayashi, N. Yukawa, H. Yoshifuji, D. Kawabata, K. Ohmura, T. Usui, T. Fujii, K. Okawa, and T. Mimori. 2010. The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatol. 49 (3): 433–440.
Nagashima, T., Y. Kamata, M. Iwamoto, H. Okazaki, N. Fukushima, and S. Minota. 2019. Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis. Rheumatology International 39 (5): 901–909.
Nissar, A.U., L. Sharma, M.A. Mudasir, L.A. Nazir, S.A. Umar, P.R. Sharma, R.A. Vishwakarma, and S.A. Tasduq. 2017. Chemical chaperone 4-phenyl butyric acid (4-PBA) reduces hepatocellular lipid accumulation and lipotoxicity through induction of autophagy. Journal of Lipid Research 58 (9): 1855–1868.
Matsumoto, M., N. Hada, Y. Sakamaki, A. Uno, T. Shiga, C. Tanaka, T. Ito, A. Katsume, and M. Sudoh. 2013. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. International Journal of Experimental Pathology 94 (2): 93–103.
Schneider, C.A., W.S. Rasband, and K.W. Eliceiri. 2012. NIH Image to ImageJ: 25 years of image analysis. Nature Methods. 9: 671–675.
Itoh, M., H. Kato, T. Suganami, K. Konuma, Y. Marumoto, S. Terai, H. Sakugawa, S. Kanai, M. Hamaguchi, T. Fukaishi, S. Aoe, K. Akiyoshi, Y. Komohara, M. Takeya, I. Sakaida, and Y. Ogawa. 2013. Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans. PLoS ONE 8 (12): e82163.
Rodriguez-Cruz, A., D. Vesin, L. Ramon-Luing, J. Zuñiga, V.F.J. Quesniaux, B. Ryffel, R. Lascurain, I. Garcia, and L. Chávez-Galán. 2019. CD3+ macrophages deliver proinflammatory cytokines by a CD3- and transmembrane TNF-dependent pathway and are increased at the BCG-infection site. Frontiers in Immunology 10: 2550.
Imaizumi, T., T. Aizawa-Yashiro, S. Watanabe, T. Matsumiya, H. Yoshida, T. Tatsuta, F. Xing, P. Meng, R. Hayakari, K. Tsuruga, and H. Tanaka. 2013. TLR4 signaling induces retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5 in mesangial cells. Journal of Nephrology 26 (5): 886–893.
Imaizumi, T., K. Murakami, K. Ohta, H. Seki, T. Matsumiya, P. Meng, R. Hayakari, F. Xing, T. Aizawa-Yashiro, T. Tatsuta, H. Yoshida, and H. Kijima. 2013. MDA5 and ISG56 mediate CXCL10 expression induced by toll-like receptor 4 activation in U373MG human astrocytoma cells. Neuroscience Research 76 (4): 195–206.
Kawaguchi, S., H. Sakuraba, T. Haga, T. Matsumiya, K. Seya, T. Endo, N. Sawada, C. Iino, H. Kikuchi, H. Hiraga, S. Fukuda, and T. Imaizumi. 2019. Melanoma differentiation-associated gene 5 positively modulates TNF-α-induced CXCL10 expression in cultured HuH-7 and HLE cells. Inflammation 42 (6): 2095–2104.
Li, H., Y. Zhou, H. Wang, M. Zhang, P. Qiu, M. Zhang, R. Zhang, Q. Zhao, and J. Liu. 2020. Crosstalk between liver macrophages and surrounding cells in nonalcoholic steatohepatitis. Frontiers in Immunology 11: 1169.
Kinoshita, M., T. Uchida, A. Sato, M. Nakashima, S. Shono, Y. Habu, H. Miyazaki, S. Hiroi, and S. Seki. 2010. Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice. Journal of Hepatology 53 (5): 903–910.
Seidman, J.S., T.D. Troutman, M. Sakai, A. Gola, N.J. Spann, H. Bennett, C.M. Bruni, Z. Ouyang, R.Z. Li, X. Sun, B.T. Vu, M.P. Pasillas, K.M. Ego, D. Gosselin, V.M. Link, L.W. Chong, R.M. Evans, B.M. Thompson, J.G. McDonald, M. Hosseini, J.L. Witztum, R.N. Gemain, and C.K. Glass. 2020. Niche-specific reprogramming of epigenetic landscapes derives myeloid cell diversity in nonalcoholic steatohepatitis. Immunity 52 (6): 1057-1074.e7.
Zheng, C., Q. Yang, C. Xu, P. Shou, J. Cao, M. Jiang, Q. Chen, G. Cao, Y. Han, F. Li, W. Cao, L. Zhang, L. Zhang, Y. Shi, and Y. Wang. 2015. CD11b regulates obesity-induced insulin resistance via limiting alternative activation and proliferation of adipose tissue macrophages. Proc Natl Acad Sci U S A. 112 (52): E7239–E7248.
Nakashima, H., M. Nakashima, M. Kinoshita, M. Ikarashi, H. Miyazaki, H. Hanaka, J. Imaki, and S. Seki. 2016. Activation and increase of radio-sensitive CD11b+ recruited Kupffer cells / macrophages in diet-induced steatohepatitis in FGF5 deficient mice. Science and Reports 6: 34466.
Mouries, J., P. Brescia, A. Silvestri, I. Spadoni, M. Sorribas, R. Wiest, E. Mileti, M. Galbiati, P. Invernizzi, L. Adorini, G. Penna, and M. Rescigno. 2019. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. Journal of Hepatology 71 (6): 1216–1228.
Funding
This work was supported by the JSPS KAKENHI Grant Number 20K08346.
Author information
Authors and Affiliations
Contributions
S. Kawaguchi: conceptualization, resources, investigation, writing—original draft. H. Sakuraba: conceptualization, resources. M. Horiuchi, J. Ding, T. Matsumiya, and K. Seya: investigation, writing—review and editing. C. Iino and T. Endo: investigation, resources. H. Kikuchi: conceptualization, resources. S. Yoshida and H. Hiraga: methodology. S. Fukuda: resources, supervision. T. Imaizumi: writing—review and editing, resources, project administration.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
All animal experiments were conducted in accordance with the Guidelines for Animal Experimentation of the Hirosaki University (Permit number: M20016). In retrospective studies using human liver biopsy specimens, informed consent was obtained from all patients in an opt-out format. This study protocol was approved by the Ethics Committee of the Hirosaki University Graduate School of Medicine (Permit number: 2018–152), and the study was performed in accordance with the 1964 declaration of Helsinki and its later amendments.
Consent for Publication
Yes.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kawaguchi, S., Sakuraba, H., Horiuchi, M. et al. Hepatic Macrophages Express Melanoma Differentiation-Associated Gene 5 in Nonalcoholic Steatohepatitis. Inflammation 45, 343–355 (2022). https://doi.org/10.1007/s10753-021-01550-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-021-01550-8